查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598812

疫苗输送设备市场：依性质、产品类型划分 - 2025-2030 年全球预测

Vaccine Delivery Devices Market by Nature (Needle Based, Needle-Less), Product Type (Jet Injectors, Microneedles, Syringes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年疫苗输送设备市场规模为69.3亿美元，预计2024年将达到76.2亿美元，复合年增长率为10.39%，到2030年将达到138.5亿美元。

疫苗输送设备市场的范围和定义包括疫苗接种所必需的设备和技术，例如注射器、喷射注射器和微针贴片。疫苗开发的快速进步和对全球免疫计划的重视推动了对这些设备的需求。疫苗输送设备对于确保疫苗的有效管理、最大限度地减少浪费和提高患者的依从性至关重要。它们的应用范围很广，延伸到医院、诊所，甚至居家医疗机构，越来越依赖自我管理方法。最终用户主要是医疗保健提供者、政府机构和预防医学领域的个人。

主要市场统计
基准年[2023] 69.3亿美元
预测年份 [2024] 76.2亿美元
预测年份 [2030] 138.5亿美元
复合年增长率（%） 10.39%

市场的关键成长要素包括无针给药系统等技术进步、疫苗接种率上升以及对流行病预防的日益关注。最新的潜在商机在于数位医疗解决方案的集成，可以提高追踪和管理的效率。由于医疗基础设施的改善和政府措施不断增多，新兴市场具有巨大的成长潜力。然而，严格的法律规范、与创新输送设备相关的高成本以及疫苗接种犹豫等挑战可能会阻碍市场成长。

创新和研究的最佳方向是开发具有成本效益、方便且无痛的给药方法，例如皮肤贴片和可摄入装置，这些方法可以改变疫苗接种模式。由于市场充满活力和竞争，企业应注重伙伴关係和协作，以促进创新和市场渗透。利用物联网和人工智慧加强研发，准确追踪和监控疫苗管理也可以为市场提供显着优势。总体而言，市场面临与监管障碍和成本相关的挑战，但对无痛、自我管理疫苗和数位医疗保健整合的努力为马苏提供了肥沃的土壤。

市场动态：揭示快速发展的疫苗传输设备市场的关键市场洞察

供需的动态交互作用正在改变疫苗输送设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病和手术的增加
    • 增加免疫计划、扩大疫苗接种倡议和宣传活动
    • 政府策略投资新疫苗研发
  • 市场限制因素
    • 缺乏适当的基础设施和高成本
  • 市场机会
    • 采用新的疫苗传输技术，包括无针技术
    • 开发安全疫苗输送新设备
  • 市场挑战
    • 血液感染疾病的感染风险与传播

波特的五力：驾驭疫苗传递设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解疫苗输送设备市场的外部影响

外部宏观环境因素在塑造疫苗传输设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解疫苗输送设备市场的竞争格局

疫苗输送设备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵疫苗传输设备市场供应商的绩效评估

FPNV定位矩阵是评估疫苗传输设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了疫苗输送设备市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对疫苗输送设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和手术的增加
      • 增加免疫规划、扩大疫苗接种工作和宣传活动
      • 政府对新疫苗研发的战略投资优势
    • 抑制因素
      • 缺乏适当的基础设施和高成本
    • 机会
      • 采用新的疫苗接种技术，例如无针技术
      • 开发安全疫苗接种的新设备
    • 任务
      • 血液传染感染疾病的感染及传播风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章疫苗传输设备市场的本质

  • 针座
  • 没有针

第七章疫苗输送设备市场：依产品类型

  • 喷射注射器
  • 微型针
  • 注射器

第八章美洲疫苗传输设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太疫苗传输设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲疫苗传输设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Becton Dickinson & Company
  • Corium, Inc.
  • Gerresheimer AG
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Medical International Technologies（MIT Canada）Inc.
  • Medline Industries, LP
  • PharmaJet, Inc.
  • Recipharm AB
  • Schott AG
  • Smith & Nephew PLC
  • Terumo Corporation
  • Viatris Inc.
Product Code: MRR-02026C4C8C99

The Vaccine Delivery Devices Market was valued at USD 6.93 billion in 2023, expected to reach USD 7.62 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 13.85 billion by 2030.

The scope and definition of the vaccine delivery devices market encompass a range of instruments and technologies essential for the administration of vaccines, including syringes, jet injectors, and microneedle patches. The necessity for these devices is driven by the rapid advancements in vaccine development and the global emphasis on immunization programs. Vaccine delivery devices are crucial in ensuring the effective administration of vaccines, minimizing wastage, and enhancing patient compliance. Their applications are broad, spanning hospitals, clinics, and even at-home healthcare settings, with an increasing reliance on self-administration methods. End-users primarily include healthcare providers, governmental agencies, and individuals in areas of preventive healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 6.93 billion
Estimated Year [2024] USD 7.62 billion
Forecast Year [2030] USD 13.85 billion
CAGR (%) 10.39%

Key growth factors in the market include technological advancements like needle-free drug delivery systems, rising vaccination coverage, and an increased focus on pandemic preparedness. Latest potential opportunities lie in the integration of digital healthcare solutions which can enhance tracking and administration efficiency. Emerging markets offer significant growth possibilities due to improved healthcare infrastructure and increasing government initiatives to boost immunization rates. However, challenges such as stringent regulatory frameworks, high costs associated with innovative delivery devices, and vaccine hesitancy can impede market growth.

Innovation and research are best directed towards developing cost-effective, convenient, and painless delivery methods, such as skin patches or ingestible devices, which could revolutionize the vaccination landscape. As the market is highly dynamic and competitive, businesses should focus on partnerships and collaborations to foster innovation and market penetration. Enhanced R&D efforts utilizing IoT and AI for precise tracking and monitoring of vaccine administration can also present significant market advantages. Overall, while the market faces challenges related to regulatory hurdles and cost, the push towards painless, self-administration vaccines, coupled with digital healthcare integration, provides a fertile ground for growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Delivery Devices Market

The Vaccine Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing chronic diseases and number of surgeries
    • Rising immunization programs, growing vaccination initiatives & campaigns
    • Favorable government strategic investment for the development of novel vaccines
  • Market Restraints
    • Lack of proper infrastructure for storage and high costs
  • Market Opportunities
    • Adoption of novel vaccine delivery technologies such as needle-free technologies
    • Developments of new devices for safe vaccine delivery
  • Market Challenges
    • Risk of infections and transmission of blood-borne infections

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Delivery Devices Market

A detailed market share analysis in the Vaccine Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Delivery Devices Market

A strategic analysis of the Vaccine Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Antares Pharma, Inc. by Halozyme, Inc., Becton Dickinson & Company, Corium, Inc., Gerresheimer AG, Inovio Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Medical International Technologies (MIT Canada) Inc., Medline Industries, LP, PharmaJet, Inc., Recipharm AB, Schott AG, Smith & Nephew PLC, Terumo Corporation, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Nature, market is studied across Needle Based and Needle-Less.
  • Based on Product Type, market is studied across Jet Injectors, Microneedles, and Syringes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing chronic diseases and number of surgeries
      • 5.1.1.2. Rising immunization programs, growing vaccination initiatives & campaigns
      • 5.1.1.3. Favorable government strategic investment for the development of novel vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of proper infrastructure for storage and high costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of novel vaccine delivery technologies such as needle-free technologies
      • 5.1.3.2. Developments of new devices for safe vaccine delivery
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infections and transmission of blood-borne infections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Delivery Devices Market, by Nature

  • 6.1. Introduction
  • 6.2. Needle Based
  • 6.3. Needle-Less

7. Vaccine Delivery Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Jet Injectors
  • 7.3. Microneedles
  • 7.4. Syringes

8. Americas Vaccine Delivery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vaccine Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Antares Pharma, Inc. by Halozyme, Inc.
  • 3. Becton Dickinson & Company
  • 4. Corium, Inc.
  • 5. Gerresheimer AG
  • 6. Inovio Pharmaceuticals, Inc.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Medical International Technologies (MIT Canada) Inc.
  • 9. Medline Industries, LP
  • 10. PharmaJet, Inc.
  • 11. Recipharm AB
  • 12. Schott AG
  • 13. Smith & Nephew PLC
  • 14. Terumo Corporation
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. VACCINE DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-LESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023